Health AI Register Logo
ProductsCompaniesNewsContact
QyScore
QyScore
QyScore
QyScore thumbnail 1
QyScore thumbnail 2
QyScore thumbnail 3

Key Features

  • Brain region quantification
  • Comparison to reference population
  • Report generation
  • White matter hyperintensities segmentation and evolution in time and space

General Information

Product name

QyScore

Company

Subspeciality

Neuro

Modality

MR, PET

Disease targeted

Dementia, Multiple sclerosis, Alzheimer's disease, neuro-degenerative diseases

Main task

Not specified

Technical Specifications

Population

Adults patients

Patient population age

Not specified

Input

1.5T and 3T scanners for T1 MRI processing, and 3T scanners for T2FLAIR MRI

Input format

DICOM

Output

Segmentation overlay, report, 3D rendering, longitudinal charts, lesion load overlay, lesion evolution chart, normative database comparison charts

Output format

.csv export of collection of patients, DICOM, DICOM Secondary capture, DICOM SEG, DICOM SR, Fused DICOM, Pdf, Structured report metadata

Integration

Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone webbased

Deployment

Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker)

Trigger for analysis

Automatically, Right after the image acquisition

Processing time

Depending on the technical workflow, T1, T1+T2 etc and the clinical needs

Regulatory Information

CE Certification

Pathway:

MDD

Class:

Class IIa

Verified by Health AI Register
FDA Certification

Pathway:

510(k) cleared

Class:

Class II

Verified by Health AI Register

Other certifications

Not specified

Market Presence

On market since

09-2017 (Europe) 12-2019 (USA)

AI Platforms

Blackford Analysis

Resellers

Not specified

Countries present

5

Paying clinical customers

< 10

Research/test users

< 10 (also in clinical trials with pharma/CRO)

Pricing Information

Pricing model

Subscription

Based on

Number of installations

Evidence & Research

Peer-Reviewed Papers

Peer-Reviewed

View

Automatic segmentation of white matter hyperintensities: validation and comparison with state-of-the-art methods on both Multiple Sclerosis and elderly subjects

Peer-Reviewed

View

Validation of an automatic tool for the rapid measurement of brain atrophy and white matter hyperintensity: QyScore®

Source: vendor | First published: Mar 27, 2022 | Last updated: Jul 9, 2025